stockrowAMNEAL PHARMACEUTICALS, INC.
AMRX Healthcare Drug Manufacturers Specialty & Generic
AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.
- Revenue
- +9.96%
- EPS
- +267.0%
- Free cash flow
- −50.9%
- Total debt
- +23.8%
Quarter to September 2026, against a year earlier
Follow AMRX
Alert me
AMNEAL PHARMACEUTICALS, INC. (AMRX) Operating margin
AMNEAL PHARMACEUTICALS, INC.'s operating margin over the twelve months to 30 September 2026 was 15.0%, up 1.9 percentage points from fiscal 2025 (13.1%). Over the past ten years it has ranged from −15.3% (fiscal 2019) to 28.0% (fiscal 2016); the current reading is higher than 82% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 13.1% | 4.13 |
| FY2024 | 8.92% | 0.38 |
| FY2023 | 8.54% | 12.83 |
| FY2022 | −4.29% | (11.58) |
| FY2021 | 7.29% | 2.72 |
| FY2020 | 4.57% | 19.86 |
| FY2019 | −15.3% | (14.11) |
| FY2018 | −1.18% | (24.89) |
| FY2017 | 23.7% | (4.27) |
| FY2016 | 28.0% | 19.90 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 11.1% | (5.24) |
| Jun 2026 | 16.3% | (3.32) |
| Mar 2026 | 19.6% | 5.86 |
| Dec 2025 | 13.8% | 4.79 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | 40.6% |
| LQDA Liquidia Corporation compare | 37.4% |
| LNTH Lantheus Holdings, Inc. compare | 18.6% |
| AMRX AMNEAL PHARMACEUTICALS, INC. | 15.0% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 13.8% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| ALKS Alkermes plc compare | 3.66% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| HIMS Hims & Hers Health, Inc. compare | −5.99% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on AMRX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement